Butamben

CHEMBL127516 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
193.2 g/mol
LogP
2.9
Phase
4

A local anesthetic ester compound that was used topically to relieve pain on mucous membranes and skin surfaces. It belongs to the same chemical class as benzocaine and works by blocking nerve conduction. It is no longer widely available and has been replaced by other topical anesthetics.

الوزن الجزيئي

193,2400 g/mol

LogP

2,90

TPSA

52,30 Ų

قاعدة ليبينسكي للخمسة

ناجح

آلية العمل

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCOC(=O)c1ccc(N)cc1

InChI

InChI=1S/C11H15NO2/c1-2-3-8-14-11(13)9-4-6-10(12)7-5-9/h4-7H,2-3,8,12H2,1H3

Molecular Formula

C11H15NO2

HBD / HBA

1 / 3

الروابط القابلة للدوران

5

الذرات الثقيلة

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

A local anesthetic ester compound that was used topically to relieve pain on mucous membranes and skin surfaces. It belongs to the same chemical class as benzocaine and works by blocking nerve conduction. It is no longer widely available and has been replaced by other topical anesthetics.

Blocks voltage-gated sodium channels in nerve cell membranes, preventing the generation and conduction of nerve impulses. This produces reversible loss of sensation in the area of application.

Yes, Butamben is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL127516. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2482. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.